Targeting Selectins and Their Ligands in Cancer

por Natoni, Alessandro, Macauley, Matthew S., O’Dwyer, Michael E.
Publicado 2016

New developments in the treatment of multiple myeloma – clinical utility of daratumumab

por McEllistrim, Cian, Krawczyk, Janusz, O’Dwyer, Michael E
Publicado 2017

Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics

por Kirwan, Alan, Utratna, Marta, O'Dwyer, Michael E., Joshi, Lokesh, Kilcoyne, Michelle
Publicado 2015

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

por Daly, John, Sarkar, Subhashis, Natoni, Alessandro, Stark, Jessica C., Riley, Nicholas M., Bertozzi, Carolyn R., Carlsten, Mattias, O'Dwyer, Michael E.
Publicado 2022

Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML

por O’ Reilly, Eimear, Dhami, Sukhraj Pal S., Baev, Denis V., Ortutay, Csaba, Halpin-McCormick, Anna, Morrell, Ruth, Santocanale, Corrado, Samali, Afshin, Quinn, John, O’Dwyer, Michael E, Szegezdi, Eva
Publicado 2018

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when

por Caers, Jo, Garderet, Laurent, Kortüm, K. Martin, O’Dwyer, Michael E., van de Donk, Niels W.C.J., Binder, Mascha, Dold, Sandra Maria, Gay, Francesca, Corre, Jill, Beguin, Yves, Ludwig, Heinz, Larocca, Alessandra, Driessen, Christoph, Dimopoulos, Meletios A., Boccadoro, Mario, Gramatzki, Martin, Zweegman, Sonja, Einsele, Hermann, Cavo, Michele, Goldschmidt, Hartmut, Sonneveld, Pieter, Delforge, Michel, Auner, Holger W., Terpos, Evangelos, Engelhardt, Monika
Publicado 2018